Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Genzyme, 8 Apr 2013
Accessed on 26 Apr 2013 from http://news.genzyme.com/press-release/genzymes-once-daily-oral-aubagio-teriflunomide-approved-argentina-treatment-relapsing-.